Enteric fever, commonly known as typhoid, is a life-threatening illness caused by the Salmonella Typhi bacteria. The disease remains a significant health concern, particularly in developing countries. This article aims to provide an updated approach to managing enteric fever effectively.
Accurate diagnosis of enteric fever is critical for successful management. Blood culture remains the gold standard, but its sensitivity is limited. Recent advances include PCR and antigen detection tests, offering improved sensitivity and specificity.
Antibiotic therapy is the cornerstone of treatment. Fluoroquinolones were once the first-line treatment, but increasing resistance has necessitated a shift towards third-generation cephalosporins and azithromycin. The choice of antibiotic should be guided by local susceptibility patterns.
Vaccination plays a pivotal role in the prevention of enteric fever. Two vaccines are currently available: Vi polysaccharide vaccine and Ty21a vaccine. Both offer substantial protection and are recommended for individuals in endemic areas and travelers to these regions.
Public health measures are integral to controlling enteric fever. These include ensuring access to clean water, improving sanitation, and promoting hand hygiene. Rapid identification and treatment of cases can also help limit transmission.
Novel diagnostic tools and vaccines are under development, promising improved management of enteric fever. However, addressing the social determinants of health is crucial to achieving lasting progress.
In conclusion, the management of enteric fever requires a multifaceted approach, encompassing accurate diagnosis, appropriate antibiotic therapy, vaccination, and public health measures. Future efforts should focus on the development of novel interventions and addressing the underlying social determinants of the disease.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation